Harvard Management Company Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPDR Gold Trust
GLD
|
+$11K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$855M |
| 2 |
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
|
+$20.5M |
| 3 |
ProShares Short VIX Short-Term Futures ETF
SVXY
|
+$11.3M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$491K |
| 5 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$167K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 72.59% |
| 2 | Healthcare | 27.41% |
Similar funds
Harvard Management Company's Q4 2017 Portfolio in Review
As of Q4 2017, Harvard Management Company held 12 positions worth $114M, down 89% from $1.02B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Harvard Management Company withdrew a net $888M in Q4 2017, closing 2 positions and reducing 9 holdings. Its most notable exit was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $855M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 73% of assets, down from 93% a quarter earlier, followed by Healthcare.
Against the trend, Harvard Management Company added an estimated $11K to SPDR Gold Trust.
- Harvard Management Company added most to SPDR Gold Trust in Q4 2017, an estimated $11K increase.
- Harvard Management Company's biggest Q4 2017 reduction was Chinook Therapeutics, Inc. Common Stock, cutting an estimated $20.5M.
- Harvard Management Company fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q4 2017, selling an estimated $855M.
- Harvard Management Company's ten largest holdings make up 100% of its $114M portfolio in Q4 2017.
- Harvard Management Company opened 0 new positions and closed 2 in Q4 2017.
- Harvard Management Company's portfolio value fell 89% quarter-over-quarter to $114M.
Based on Harvard Management Company's 13F filing for Q4 2017, filed 9 Feb 2018.